Clearstead Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Clearstead Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.4K	Sell	116 -31	-21%	-$10.5K	﹤0.01%	1330
2025 Q4	$58.5K	Sell	147 -617	-81%	-$273K	﹤0.01%	1333
2025 Q3	$348K	Sell	764 -359	-32%	-$146K	0.01%	740
2025 Q2	$366K	Sell	1,123 -181	-14%	-$50.1K	0.01%	697
2025 Q1	$352K	Buy	1,304 +194	+17%	+$49.9K	0.01%	663
2024 Q4	$261K	Hold	1,110	–	–	﹤0.01%	774
2024 Q3	$305K	Hold	1,110	–	–	﹤0.01%	721
2024 Q2	$270K	Buy	1,110 +1,000	+909%	+$158K	﹤0.01%	720
2024 Q1	$16.5K	Sell	110 -708	-87%	-$118K	﹤0.01%	973
2023 Q4	$157K	Sell	818 -5,218	-86%	-$889K	0.01%	494
2023 Q3	$1.07M	Buy	6,036 +4,518	+298%	+$862K	0.03%	296
2023 Q2	$288K	Hold	1,518	–	–	0.02%	377
2023 Q1	$304K	Buy	1,518 +10	+0.7%	+$2.1K	0.02%	337
2022 Q4	$358K	Hold	1,508	–	–	0.03%	300
2022 Q3	$302K	Sell	1,508 -3,040	-67%	-$580K	0.03%	308
2022 Q2	$663K	Buy	4,548 +40	+0.9%	+$5.67K	0.05%	215
2022 Q1	$736K	Buy	4,508 +1,398	+45%	+$213K	0.05%	220
2021 Q4	$527K	Buy	3,110 +110	+4%	+$20.4K	0.04%	250
2021 Q3	$566K	Hold	3,000	–	–	0.04%	227
2021 Q2	$509K	Hold	3,000	–	–	0.04%	228
2021 Q1	$424K	Hold	3,000	–	–	0.04%	238
2020 Q4	$390K	Hold	3,000	–	–	0.04%	230
2020 Q3	$437K	Hold	3,000	–	–	0.05%	193
2020 Q2	$444K	Hold	3,000	–	–	0.05%	187
2020 Q1	$327K	Hold	3,000	–	–	0.05%	189
2019 Q4	$346K	Hold	3,000	–	–	0.04%	211
2019 Q3	$241K	Hold	3,000	–	–	0.03%	233
2019 Q2	$218K	Hold	3,000	–	–	0.03%	255
2019 Q1	$280K	Hold	3,000	–	–	0.04%	221
2018 Q4	$219K	Hold	3,000	–	–	0.03%	232
2018 Q3	$263K	Hold	3,000	–	–	0.04%	204
2018 Q2	$295K	Hold	3,000	–	–	0.04%	193
2018 Q1	$357K	Hold	3,000	–	–	0.05%	167
2017 Q4	$381K	Hold	3,000	–	–	0.05%	162
2017 Q3	$352K	Hold	3,000	–	–	0.05%	180
2017 Q2	$239K	Buy	+3,000	New	+$192K	0.03%	210